OSHA's beryllium standard requires a licensed physician to send the employer a written medical opinion after each beryllium medical surveillance exam. Its content is strictly limited by 29 CFR 1910.1024(k)(6), and anything about exposure limits, chronic beryllium disease (CBD) referral, continued surveillance or medical removal needs the employee's written authorization. OSHA publishes no form for it.
The licensed physician who performed or directed the beryllium surveillance exam writes the whole opinion. A separate written medical report, with fuller results, goes to the employee under 1910.1024(k)(5).
The issuer sets what the letter or report must contain; check its current rules before you write it.
Licensed Physician's Written Medical Opinion for the Employer (Beryllium)
There is no form to fill: the program asks for a letter or report with the content it sets. Vero Scribe writes the visit note it draws on, so the details are ready when you write it.
A form is listed only after its name and number were confirmed on the issuing agency’s or insurer’s own website, or in the form itself. Each entry links to that source. The list was last checked in October 2026. Forms and their requirements change without notice, so check the official page for the current version before you complete one.
Vero is not affiliated with, or endorsed by, the agencies and insurers listed here. Read our editorial policy.
Once the employer receives an opinion recommending referral, it must provide an evaluation at a chronic beryllium disease diagnostic center within 30 days, at no cost to the employee. Testing can include pulmonary function tests, bronchoalveolar lavage and transbronchial biopsy. The referral appears in the employer's opinion only with the employee's written authorization.
Yes, but only with the employee's written authorization and when the employee is confirmed positive or has CBD. Medical removal lets an eligible employee move to comparable work below the action level, or stay and use a respirator, with earnings and seniority protected for up to six months.